 | Up a level |
2019
Ascierto, Paolo A., Long, Georgina V., Robert, Caroline 
ORCID: 0000-0002-9493-0238, Brady, Benjamin, Dutriaux, Caroline, Di Giacomo, Anna Maria, Mortier, Laurent, Hassel, Jessica C., Rutkowski, Piotr ORCID: 0000-0002-8920-5429, McNeil, Catriona, Kalinka-Warzocha, Ewa, Savage, Kerry J., Hernberg, Micaela M., Lebbe, Celeste, Charles, Julie, Mihalcioiu, Catalin, Chiarion-Sileni, Vanna, Mauch, Cornelia, Cognetti, Francesco, Ny, Lars ORCID: 0000-0003-3864-5958, Arance, Ana, Svane, Inge Marie ORCID: 0000-0002-9451-6037, Schadendorf, Dirk, Gogas, Helen, Saci, Abdel, Jiang, Joel, Rizzo, Jasmine and Atkinson, Victoria
(2019).
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy Three-Year Follow-up of a Randomized Phase 3 Trial.
JAMA Oncol., 5 (2).
S. 187 - 195.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 2374-2445
2017
Popat, Sanjay ORCID: 0000-0003-2087-4963, Ardizzoni, Andrea, Ciuleanu, Tudor, Dols, Manuel Cobo, Laktionov, Konstantin, Szilasi, Maria, Califano, Raffaele, Costa, Enric Carcereny, Griffiths, Richard, Paz-Ares, Luis, Szczylik, Cezary, Jaime, Jesus Corral, Isla, Dolores, Jassem, Jacek, Appel, Wiebke, van Meerbeeck, Jan, Wolf, Juergen, Jiang, Joel, Molife, L. Rhoda and Felip, Enriqueta
(2017).
Nivolumab in Patients With Previously TreatedMetastatic Squamous Non-Small Cell Lung Cancer (NSCLC): Results of A European Single-Arm, Phase II Trial (CHECKMATE 171) Including Patients Aged >= 70 Years or With Poor Performance Status.
Asia-Pac. J. Clin. Oncol., 13.
S. 149 - 151.
HOBOKEN:
WILEY.
ISSN 1743-7563